Bruno Vincenzi

8PUBLICATIONS
175CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersAboriginal and Torres Strait Islander marketingCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 28, 2025
Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.

Sabina Barresi, Roberto Passa, Silvia Vallese

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

|Oct 05, 2022
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.

Bruno Vincenzi, Andrea Napolitano, Alessandro Comandone

|Apr 08, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah

|Aug 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.

Marco Russano, Alessio Cortellini, Raffaele Giusti

Pageof 2

Frequent Collaborators

4 joint publications

Giuseppe Tonini

3 joint publications

Alessio Cortellini

3 joint publications

Grazia Armento

2 joint publications

Alessandro Russo